- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.10.25 | Roche's small cell lung cancer therapy approved by FDA | ||
| 06.10.25 | Indegene acquires BioPharm to advance AI-driven life sciences marketing | ||
| 06.10.25 | The impact of US tariffs on healthcare and life sciences multinationals | ||
| 03.10.25 | Eli Lilly's Inluriyo approved by FDA for breast cancer | ||
| 03.10.25 | FDA accepts supplemental New Drug Application for Pharming's paediatric immunodeficiency therapy | ||
| 03.10.25 | Porterhouse appoints Jennifer Stewart as Medical Director in US | ||
| 03.10.25 | What does it mean to improve outcomes for patients with chronic conditions? | ||
| 02.10.25 | BMS, Takeda and Astex join AI training consortium | ||
| 02.10.25 | J&J's Tremfya approved by FDA for children with plaque psoriasis and psoriatic arthritis | ||
| 02.10.25 | Smarter strategies for systematic literature reviews | ||
| 01.10.25 | Pfizer agrees pricing and distribution deal with US government | ||
| 01.10.25 | Amgen commits $650m to US manufacturing expansion | ||
| 01.10.25 | EU medicine shortages hit record highs in 2023 and 2024 | ||
| 01.10.25 | From instinct to insights: how data is transforming medical communications | ||
| 30.09.25 | Lilly's early Alzheimer's disease treatment approved in the EU | ||
| 30.09.25 | GSK names Luke Miels as next CEO | ||
| 30.09.25 | Launch excellence: innovative thinking meets insightful strategy | ||
| 29.09.25 | Roche's Lunsumio receives positive CHMP opinion for follicular lymphoma | ||
| 29.09.25 | University of Liverpool identifies new class of antibiotic in fight against AMR | ||
| 29.09.25 | Biopharma 2030 challenge: scaling product launches without growing teams | ||
| 26.09.25 | Ipsen's tumour treatment receives MHRA marketing authorisation | ||
| 26.09.25 | NHS launches National Commission to strengthen AI regulation | ||
| 26.09.25 | Will data and AI prove to be the game-changer that transforms launch excellence? | ||
| 26.09.25 | New survey: Europeans seek better health equity in breast cancer awareness | ||
| 25.09.25 | Novartis announces new data supporting MS therapy Kesimpta |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .